Menu Back toSession-7-Public-Accountability-Around-Disclosure

Global Clinical Trials Transparency Conference

Session 7: Public Accountability Around Disclosure and Where Are We Heading?

Session Chair(s)

Merete  Joergensen, MBA, MSc

Merete Joergensen, MBA, MSc

  • Senior Trial Disclosure Director, Clinical Reporting Anchor & Disclosure
  • Novo Nordisk A/S, Denmark
New initiatives on how to improve, enforce and measure Data Sharing activities are being implemented and published. How are these measured? What has the impact been? How have organisations worked with these new initiatives? Future transparency ambitions, and how can we even get more out of these new initiatives?


Trish  Groves

Trish Groves

  • Deputy Editor
  • British Medical Journal, United Kingdom
Lise  Baltzer

Making Publications, Disclosure and Data Sharing Commitments Go Hand in Hand

Lise Baltzer

  • Director for Global Publications
  • Novo Nordisk, Denmark
Jennifer  Miller, PhD

Data sharing the new initiative under the Good Pharma Score Card

Jennifer Miller, PhD

  • Assistant Professor
  • Yale School of Medicine, United States
Ben  Goldacre

FDAAA TrialsTracker and the COMPare Trials project

Ben Goldacre

  • Senior Clinical Research Fellow, CEBM, Department of Primary Care Health Science
  • University of Oxford, United Kingdom